In the recently published Future Effective Local Coverage Determinations (LCDs) for Skin Substitutes, we are pleased to announce that MIMEDX products, EPIFIX (Q4186) and EPICORD (Q4187), are listed as COVERED by all seven Medicare Administrative Contractors (MACs).? ? Learn more: https://lnkd.in/ehXBFVtj ? #MIMEDX #EPIFIX #EPICORD #SkinSubstitutes #Reimbursement #LCDs #Medicare?
关于我们
MIMEDX is a pioneer and leader in the field of placental tissue. With more than a decade of helping clinicians manage chronic and hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical settings of healthcare. The Company's vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life.
- 网站
-
https://www.mimedx.com
MiMedx的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 501-1,000 人
- 总部
- Marietta,Georgia
- 类型
- 上市公司
- 创立
- 2008
- 领域
- Biomaterials、Sports Medicine、Orthopedics、Spine、Wound Care、Burn和Surgical
地点
MiMedx员工
动态
-
Thank you to everyone who joined us at the Medical Education Strategy & Innovation Summit!?Our keynote speaker, Kathleen D. Schaum, MS,?gave her expert insights into reimbursement in wound care, especially relating to the recently published Local Coverage Determinations. As we wrap up all Summits for 2024, we’re grateful for the chance to foster collaboration and share knowledge across the healthcare community. Here's to continuing to innovate and elevate patient care together. Cheers to all who made these summits a success! Learn more about our Medical Education resources: https://mimedx.info/MED-ED #MIMEDX #MedicalEducation #HealthcareInnovation #WoundCare #Reimbursement #ThankYou
-
MiMedx转发了
Wound Care Advances: Cost-Effectiveness Analysis of Dehydrated Human Amnion/Chorion Membrane for Treating Venous Leg Ulcers Yields a Lower Per-Patient Cost A recent study declared DHACM to be a cost-effective alternative to non-advanced therapies for Medicare patients with a complex venous leg ulcer. Read more here: https://okt.to/iJnw7Y Sponsored by MIMEDX
-
MIMEDX leads the way with seven Level I RCTs validating the safety and efficacy of EPIFIX? and EPICORD? allografts. Clinicians can trust in our evidence-based solutions to enhance patient care. Get started with MIMEDX? advanced wound solutions today: https://bit.ly/3YgoCYk #MIMEDX #WoundCare #ClinicalResearch #SkinSubstitutes
-
Tune-in to our presentation at the 2024 Stifel Healthcare Conference this morning! MIMEDX CEO Joe Capper will detail the Company’s latest updates for the investment community, beginning at 9:45 a.m. ET. Follow the link to register: https://lnkd.in/eziY7Avp
-
MIMEDX supports CMS, the MACs, and all stakeholders involved in the implementation of LCDs for skin substitutes that address severe shortfalls with the Medicare reimbursement system while ensuring patients have access to clinically proven solutions. Our team is ready to assist in this transition with educational programs and local reimbursement support, and our focus remains on advancing the standard of patient care. Read the full press release: https://lnkd.in/euNfPX2Z
-
Education is key to adapting to changes in healthcare. MIMEDX is here to help you with our comprehensive resources and support network. From reimbursement coverage to advanced wound care solutions, we’ve got you covered. Explore our offerings and join a community dedicated to patient success: https://bit.ly/47VTYaF #MIMEDX #Reimbursement #WoundCare
-
Today, we honor the courage and sacrifices of our Veterans and Service Members. We are grateful for your service and dedication to our country. #VeteransDay
-
Want to optimize patient care while cutting costs? MIMEDX’s 5 Medicare Big Data Claims reviews prove it’s possible. Discover how our products are reshaping the landscape of wound care, one successful outcome at a time: https://bit.ly/41mNpLw ?#MIMEDX #HealthcareEfficiency #WoundCare #Medicare
-
We just wrapped up another successful Summit focused on hot topics in wound care and reimbursement in Las Vegas, NV! A huge thank you to our amazing speakers who brought their expertise and passion to the stage. Kathleen Schaum, MS, President and Founder of Kathleen D. Schaum & Associates, Inc., shared her invaluable insights as a wound/ulcer management reimbursement strategy consultant and educator. Vickie Driver, DPM, MS, FACFAS, a renowned podiatric surgeon, also delivered an inspiring session that informed and motivated us all. ? Don't miss out on the last chance to attend our final summit of 2024! Secure your spot now and be part of the conversation: https://lnkd.in/eAk7niKt ? #MIMEDX #MedicalEducation #Reimbursement #WoundCare #Podiatry #SkinSubstitutes